INTRODUCTION
Older age is one of the greatest risk factors for developing cancer. Because of the aging of the global population, we are in the midst of a rise in the number of cancer cases among older adults. To deliver the best possible care to these older patients with cancer, factors other than those related to the tumor itself need to be taken into account, and conducting a geriatric assessment that includes an evaluation of functional status, comorbidities (including a self-reported assessment of hearing and vision), cognition, psychological state, nutritional status, and social support is recommended. 1 Previous studies have shown that information obtained using a geriatric assessment can uncover problems that generally are not identified through usual oncological evaluations and guide interventions to address these areas of vulnerability. 2 The geriatric assessment includes an evaluation of the individual's hearing and vision, which are critical components of the health of older individuals. 3 Sensory impairments are increasingly prevalent because of the increasing number of older adults worldwide. 4, 5 In the United States, 1 of every 6 older adults has impaired vision, 1 of 4 has impaired hearing, and up to 21% have both visual and hearing impairments (dual sensory impairment). 6, 7 Sensory impairments have negative consequences for older adults living in the community, and individuals with impairments have worse functional status, cognition, and psychological well-being, as well as poorer survival. [8] [9] [10] [11] Dual sensory impairment in particular is associated with functional decline and carries a higher risk of all-cause mortality compared with single impairments. 9, 12 Our group previously has shown that self-reported hearing impairment is associated with an increased risk of grade 3 to 5 chemotherapy-related toxicity (according to the National Cancer Institute Common Terminology Criteria for Adverse Events v3.0) in older patients with solid tumors. 13, 14 However, to the best of our knowledge, information regarding the association between sensory impairment and the well-being of older adults with cancer is lacking. In the current study, we described the prevalence of self-reported hearing, visual, and dual sensory impairment in older adults with cancer who were initiating chemotherapy and analyzed its association with the functional status, psychological state, and cognition of the patients.
MATERIALS AND METHODS

Patients and Measures
The current study was a secondary analysis of 2 prospective studies that included 750 patients aged 65 years with stage I to IV solid tumors (according to the TNM staging system) who were initiating a new chemotherapy regimen (Fig. 1A) . The goal of the first study was to use a geriatric assessment tool to identify clinical predictors of chemotherapy toxicity in 500 older adults with cancer who were receiving standard chemotherapy treatment. 13 The results of this study led to the development of the Cancer and Aging Research Group (CARG) chemotherapy toxicity calculator (available at http://www.mycarg. org/Chemo_Toxicity_Calculator), which can be used to predict the risk of grade 3 to 5 chemotherapy toxicity. 13 The second study had identical inclusion criteria and validated the predictive model in an independent cohort of 250 patients.
14 Both received approval from the institutional review boards of participating institutions, and informed consent was obtained from each participant.
All 750 patients included in both studies completed a baseline geriatric assessment that included measures of functional status, comorbidity, polypharmacy, social functioning, social support, psychological status, nutritional status, and cognition (Table 1) . [13] [14] [15] [16] [17] [18] The (Fig. 1B) . 15 These questions asked patients to rate their eyesight (with glasses or contacts) and their hearing (with a hearing aid, if needed) as "excellent," "good," "fair," "poor," or "totally deaf/ blind." Patients who rated both their eyesight and their hearing as "excellent" or "good" were considered to have no impairments. Patients who rated either their eyesight or their hearing as "fair," "poor," or "totally deaf/blind" were considered to have a single impairment (visual or hearing). Patients who rated both their eyesight and their hearing as "fair," "poor," or "totally deaf/blind" were considered to have dual impairment. Patients with moderate and major sensory impairments were pooled together based on existing definitions of sensory impairment and on previous data demonstrating similar associations between various degrees of impairment and outcomes. 6, 19 
Outcomes
The objective of the current study was to examine the association between hearing, visual, and dual sensory impairment and the patients' functional status, psychological status, and cognition at baseline (Table 1) . [13] [14] [15] [16] [17] [18] Patients were considered to have deficits in functional status if they reported to be dependent in at least 1 instrumental activity of daily living (IADL) item or had a score of <75 in the RAND Health Medical Outcomes Study (MOS) Physical Health Scale (a self-reported tool capturing limitations in a broad range of physical functioning from ADL [such as bathing] to vigorous activities [such as running]). 15, 16 Depression was defined as a score of 6 in the Hospital Anxiety and Depression Scale (HADS) depression subscale. 17 Anxiety was defined as a score of 6 in the HADS anxiety subscale. 17 Abnormal cognitive screening was defined as a score of 11 in the Blessed Orientation-Memory-Concentration test (BOMC). 18 Descriptive analyses were performed to summarize patient, tumor, and treatment characteristics and geriatric assessment results. One-way analysis of variance and chisquare tests were used to examine the differences between patients who did not report any impairment and those who reported single or dual impairments in terms of demographic factors, tumor and treatment characteristics, and geriatric assessments. Logistic regression was used to analyze the association between sensory impairment and physical function, anxiety, depression, and cognition, which were considered as dependent variables. Final multivariate analysis included those variables that were significant on univariate analysis and was adjusted for age, sex, race, educational level, cancer type/stage, comorbidities, number of falls, number of medications, and social support. Data were analyzed using SAS statistical software (version 9.3; SAS Institute Inc, Cary, North Carolina). All statistical tests were 2-sided and P values < .05 were considered statistically significant.
RESULTS
Patient Characteristics
A total of 750 patients aged 65 years were included in the current analysis. The median age of the patients was 72 years (range, 65-94 years); 56% of patients (419 patients) were male and 84% (632 patients) were nonHispanic white. Approximately 61% (460 patients) had an educational level of college and 15% (112 patients) were employed. Approximately 58% of the patients (436 patients) had stage IV disease. The most common tumor types were breast/gynecological (29%; 221 patients), lung (28%; 207 patients), and gastrointestinal (27%; 203 patients) ( Table 2 ). Approximately 36% of the patients (268 patients) reported at least 1 sensory impairment: 18% (129 patients) reported hearing impairment alone, 11% (84 patients) reported visual impairment alone, and 7% (55 patients) reported dual sensory impairment. Patients who reported impairments were more likely to be older (P < .01), female (P < .01), retired or unemployed (P < .01), have a lower educational level (P < .01), and have worse social support (P 5 .02).
Sensory Impairment and Functional Status
Approximately 42% of the patients (314 patients) were dependent in at least 1 IADL, whereas 50% (371 patients) had an MOS Physical Health Scale score of <75. Patients reporting sensory impairments were more likely to report being dependent in at least 1 IADL and to have a score of <75 on the MOS Physical Health Scale (Table 3 ). In univariate analysis ( 
Sensory Impairment and Psychological Status and Cognition
Approximately 24% of the patients (178 patients) met HADS criteria for depression, and 36% (269 patients) met HADS criteria for anxiety. Only 6% of patients (44 patients) had an abnormal cognitive screening in the BOMC. Patients reporting sensory impairments were significantly more likely to meet HADS criteria for anxiety and depression, and to have an abnormal cognitive screening on the BOMC (Table 3 ). In univariate analysis (Table  4) , hearing impairment (OR, 1.8; 95% CI, 1.1-2.8 [P 5 .01]), visual impairment (OR, 3.1; 95% CI, 1.9-5.2 [P < .01]), and dual impairment (OR, 3.6; 95% CI, 2.0-6.4 [P < .01]) were found to be associated with depression. Hearing impairment (OR, 1.6; 95% CI, 1.0-2.3 [P 5 .03]), visual impairment (OR, 1.6; 95% CI, 1.0-2.6 [P 5 .04]), and dual impairment (OR, 2.6; 95% CI, 1.5-4.6 [P < .01]) were associated with anxiety. Only dual impairment was found to be significantly associated with cognitive deficit (OR, 4.3; 95% CI, 1.9-9.9 [P < .01]).
In multivariate analyses ( 
DISCUSSION
Sensory impairment is common among older adults with solid tumors, with greater than one-third reporting at least 1 impairment and nearly 10% reporting both visual and hearing impairments. Furthermore, older patients with cancer and sensory impairment are more likely to have concurrent functional, psychological, and cognitive deficits. This is particularly true for patients reporting dual sensory impairment.
Hearing and visual impairments represent a global public health problem, particularly for older adults. According to the World Health Organization, 164.5 million individuals aged 65 years have disabling hearing impairment globally, meaning that one-third of the world's older adults are affected by hearing loss. 4, 20 An additional 185 million individuals aged 50 years have disabling visual impairment, mostly because of potentially correctable causes, such as cataracts or refraction problems. 5, 6 In the United States, according to the National Health and Nutrition Examination Survey, visual impairment is found in approximately 15.4% of older adults, whereas hearing impairment is present in 26.3%. Furthermore, dual sensory impairment has been reported in up to 6% of older adults in the United States. 6 Among older cancer survivors in the United States, the prevalence of hearing and visual impairment was found to be 7.4% and 7.8%, respectively, which was higher than that reported by older Medicare beneficiaries without a history of cancer. 21 However, a recent study linking the Surveillance, Epidemiology, and End Results registry and the Medicare Health Outcomes Survey data found that hearing and visual impairments among cancer survivors (mean time from diagnosis of 12.4 months) had a prevalence very similar to that of controls. 22 However, to the best of our knowledge, few studies to date have examined the prevalence of sensory impairment among older patients with cancer who are receiving chemotherapy. Even the largest cohort studies in which a geriatric assessment was included as part of the pretreatment evaluation of older adults with cancer did not report the prevalence of sensory impairments. 23, 24 In community-dwelling older adults, sensory impairment is associated with a higher incidence of depression, lower social activity, cognitive decline, functional dependence, and higher overall mortality. 25, 26 A study of 1611 older adults in Australia found that patients with hearing loss had higher depressive symptoms, which in turn appeared to be a consequence of difficulties with performing ADLs and less social participation. 9 Older adults with moderate/severe hearing loss also are at higher risk of cognitive decline, and demonstrate a higher incidence of dementia compared with those with normal hearing. 27 A study of the Canadian Health and Activity Limitation Survey also found that older adults with sensory impairment were more likely to be dependent in IADL. This was particularly prevalent among individuals with dual sensory impairment, with 68.5% requiring assistance in at least 1 IADL. 11 Finally, dual sensory impairment appears to be an independent predictor of total mortality in older adults, particularly those with concurrent cognitive impairment. 25 In the Australian Blue Mountains Eye Study, for example, participants with dual sensory impairment had a higher 10-year mortality (hazard ratio, 2.19; 95% CI, 1.2-4.0) than those without impairments. 12 A potentially relevant aspect of understanding the effect of sensory impairment on the outcomes of older adults with cancer is the implementation of strategies aimed at improving or ameliorating those deficits. Studies conducted in other settings have demonstrated that correcting visual impairment using eye glasses or refractive surgery may improve quality of life and cognition in older adults, and reduce the risk of falling. [28] [29] [30] Likewise, treating hearing loss in community-dwelling older adults using hearing aids or cochlear implants leads to an improvement in anxiety, depressive symptoms, health status, cognitive function, and quality of life. [31] [32] [33] It remains to be seen whether implementing interventions aimed at ameliorating or reducing sensory impairments in older adults with cancer who are undergoing treatment will lead to an improvement in other geriatric assessment domains, treatment tolerability, or cancer-related outcomes.
Oncologists treating older adults with cancer should assess the vision and hearing of their patients, and sensory impairment should be considered when developing a treatment plan. For example, older adults with vision impairment are more likely to have difficulty managing medications and to report increased anxiety related to medication management. 34 Furthermore, our group previously identified hearing impairment as a risk factor for grade 3 to 5 chemotherapy toxicity among older adults. To the best of our knowledge, the reason for this relationship is not completely clear and warrants further investigation. Although this could be explained by considering hearing impairment as a global marker of physiologic decline, it also could be a reflection of whether the patient can hear and understand instructions regarding potential adverse effects and indications as to when to seek medical attention. 13 Because sensory impairments are associated with deficits in other geriatric domains, identifying vision or hearing loss in an older adult with cancer could represent a useful trigger leading to an in-depth evaluation of physical limitations and psychological and cognitive deficits. Furthermore, efforts should be made to improve the way in which treatment instructions and consent processes are presented to older patients with sensory impairments.
The current study has limitations. Data regarding sensory impairment were self-reported rather than objectively measured, and therefore the true prevalence of visual or hearing impairment may be different. It is important to note that previous studies have shown that audiometric hearing impairment may be associated with different outcomes compared with self-reported hearing impairment. 35 However, current recommendations for screening for sensory impairments in older adults do not include the performance of objective screening tests such as audiometry, and self-report remains the main trigger for further evaluation. [36] [37] [38] The current study included patients with all types and stages of solid tumors at various points in their disease trajectory, comprising a heterogeneous population with differing prognosis and symptoms. However, this also may be a strength because sensory impairment may have relevance despite the tumor type. The tools used to assess psychological and cognitive impairment (HADS and BOMC) are designed for screening, and may not necessarily reflect a diagnosis of depression, anxiety, or dementia. We also did not obtain data regarding the patients' income, which may be a relevant variable. However, we did assess educational level, which is a frequently used and valuable indicator of socioeconomic status. 39 In addition, because of the nature of the data in the current study, we were not able to assess the timing of hearing or visual impairment in relation to the appearance of other deficits. Finally, it must be emphasized that the current analysis did not establish causal relationships between sensory impairments and other deficits identified by geriatric assessment.
Among older adults with cancer initiating a new line of chemotherapy, nearly 40% reported having at least 1 sensory impairment, with 7% reporting both visual and hearing impairments. Older adults with cancer in whom sensory impairments are identified are more likely to have functional, cognitive, and psychological deficits, and they should be evaluated promptly using a full geriatric assessment. Future studies should be designed to test the effect of interventions aimed at improving visual and hearing impairments on the outcomes of older patients with cancer.
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